May non-metastatic clinically localized castration-resistant prostate cancer after primary androgen ablation benefit from salvage prostate radiotherapy?

详细信息    查看全文

• 作者：Angela Botticella (1)
  Alessia Guarneri (1)
  Andrea Riccardo Filippi (1)
  Niccol貌 Giaj Levra (1)
  Fernando Munoz (1)
  Riccardo Ragona (1)
  Paolo Gontero (2)
  Umberto Ricardi (1)
  
• 关键词：Prostate adenocarcinoma ; Primary androgen deprivation therapy (ADT) ; Salvage external beam radiotherapy (EBRT) ; Rising prostate ; specific antigen (PSA) ; Non ; metastatic castration ; resistant prostate cancer (CRPC)
• 刊名：Journal of Cancer Research and Clinical Oncology
• 出版年：2013
• 出版时间：November 2013
• 年：2013
• 卷：139
• 期：11
• 页码：1955-1960
• 全文大小：194KB
• 参考文献：1. Akimoto T, Kitamoto Y, Saito J et al (2004) External beam radiotherapy for clinically node-negative, localized hormone-refractory prostate cancer: impact of pretreatment PSA value on radiotherapeutic outcomes. Int J Radiat Oncol Biol Phys 59:372鈥?79 CrossRef
  2. Cooperberg MR, Broering JM, Carroll PR (2010) Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 28:1117鈥?123 CrossRef
  3. Gogna NK, Baxi S, Hickey B et al (2012) Split-course, high-dose palliative pelvic radiotherapy for locally progressive hormone-refractory prostate cancer. Int J Radiat Oncol Biol Phys 83:e205鈥揺211
  4. Guarneri A, Botticella A, Ragona R et al (2013) Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma. World J Urol 31:411鈥?15 CrossRef
  5. Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59:61鈥?1 CrossRef
  6. Ko EC, Stone NN, Stock RG (2012) PSA nadir of <0.5聽ng/mL following brachytherapy for early stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure. Int J Radiat Oncol Biol Phys 83:600鈥?07 CrossRef
  7. Lankford SP, Pollack A, Zagars GK (1995) Radiotherapy for regionally localized hormone refractory prostate cancer. Int J Radiat Oncol Biol Phys 33:907鈥?12 CrossRef
  8. Mohler JL, Armstrong AJ, Bahnson RR et al (2012) Prostate cancer, version 3.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 10:1081鈥?087
  9. Nakamura K, Teshima T, Takahashi Y et al (2004) Radiotherapy for localized hormone-refractory prostate cancer in Japan. Anticancer Res 24:3141鈥?146
  10. Oefelein MG, Agarwal PK, Resnick MI (2004) Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era. J Urol 171:1525鈥?528 CrossRef
  11. Ogawa K, Nakamura K, Sasaki T et al (2009) External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12聽months. Int J Radiat Oncol Biol Phys 74:759鈥?65 CrossRef
  12. Ray ME, Thames HD, Levy LB et al (2006) PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis. Int J Radiat Oncol Biol Phys 64:40鈥?0 CrossRef
  13. Roach MIII, Hanks G, Thames H et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65:965鈥?74 CrossRef
  14. Sanguineti G, Marcenaro M, Franzone P et al (2004) Is there a 鈥淐urative鈥?role of radiotherapy for clinically localized hormone refractory prostate cancer. Am J Clin Oncol 27:264鈥?68 CrossRef
  15. Sasaki T, Nakamura K, Ogawa K et al (2009) Radiotherapy for patients with localized hormone-refractory prostate cancer: results of the patterns of care study in Japan. BJU Int 104:1462鈥?466 CrossRef
  16. Shamash J, Davies A, Ansell W et al (2008) A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer. Br J Cancer 98:22鈥?4 CrossRef
  17. Smith MR, Kabbinavar F, Saad F et al (2005) Natural history of rising serum prostate-specific antigen in men with castrate non metastatic prostate cancer. J Clin Oncol 23:2918鈥?925 CrossRef
  
• 作者单位：Angela Botticella (1)
  Alessia Guarneri (1)
  Andrea Riccardo Filippi (1)
  Niccol貌 Giaj Levra (1)
  Fernando Munoz (1)
  Riccardo Ragona (1)
  Paolo Gontero (2)
  Umberto Ricardi (1)
  
  1. Radiation Oncology Unit, Department of Oncology, University of Torino, Via Genova 3, 10126, Turin, Italy
  2. Department of Urology, San Giovanni Battista Hospital, University of Torino, 10126, Turin, Italy
  
• ISSN：1432-1335

文摘